ECGXplain
AI explainability feature for ECG interpretations
Software · EmbeddedCompany source
Company profile
About Powerful Medical
Powerful Medical provides AI-powered cardiac care from instant ECG interpretation to acute pathway coordination, screening, and monitoring.
Company description Powerful Medical official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Work at Powerful Medical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- 50+ ECG findings
- Acute coronary occlusion
- Arrhythmias
- Atrial fibrillation
- Reduced left ventricular ejection fraction (LVEF)
- ST-elevation myocardial infarction (STEMI)
- STEMI-equivalent patterns
Who it serves
- Cardiology Departments
- Emergency Departments
- Emergency Medical Services (EMS)
- Health Systems
- Hospitals
- Individual Clinicians
- Primary Care Physicians
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Geographic context
MarketsBelgium · European Union · Global (150+ hospitals across three continents) · United Kingdom
Company sourceOfficial website
Company milestones
Platform expansion
Received €40 million IPCEI non-dilutive grant (2025). Won MedTech Innovator 2025. FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model (2025). Launched PMcardio for Individuals 3.0 (2025). AZORG deployment results showing 48-minute treatment time reduction (2026).
Partnerships
Recorded partners
- AZORG Health System (Belgium)
- Bupa
- East Midlands Clinical Networks
- Heart Center Aalst
- Hennepin County Medical Center
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
PMcardio for Individuals
Second opinion tool for instant AI-powered ECG interpretations in your pocket
Software · Cloud SaaSCompany source
PMcardio for Organizations
Cardiac Care Coordination Platform for accurate diagnosis at first patient contact
Platform · Cloud SaaSCompany source
PMcardio LVEF AI (LVsense)
Detect reduced left ventricular ejection fraction directly from any 12-lead ECG
Model · EmbeddedCompany source
PMcardio Platform
AI-powered ECG analysis and cardiac care coordination platform for clinicians and health systems
Platform · Cloud SaaSCompany source
PMcardio STEMI AI (Queen of Hearts)
Detect acute STEMI and occlusive MI including subtle STEMI equivalents
Model · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Improved Detection of Acute Coronary Occlusion Myocardial Infarction by an Artificial Intelligence Electrocardiogram Model in Swedish Emergency Departments.Journal of the American College of Emergency Physicians open · Oct 1, 2026
Performance of Artificial Intelligence-Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction.JACC. Advances · Apr 1, 2026
AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non-ST-Segment Elevation Acute Coronary Syndrome.JACC. Advances · Apr 1, 2026
Artificial Intelligence in detection of acute coronary occlusion in NSTEMI patients.Current problems in cardiology · Mar 1, 2026
AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry.JACC. Cardiovascular interventions · Jan 26, 2026
Association Between Artificial Intelligence-Detected Features on the ECG and Presence of Microvascular Obstruction.Circulation. Cardiovascular interventions · Jan 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
2x sensitivity for early STEMI detection
Often on the very first ECG
60% reduction in false STEMI alarms
Preventing false positive cath lab activations
98.3% accuracy for atrial fibrillation detection
On par with board-certified cardiologists
48-minute average reduction in time to treatment
AZORG Health System implementation
Up to 6 hours earlier treatment in complex cases
AZORG Health System implementation
120,000+ heart attacks detected
Cumulative platform impact
2.5M+ ECGs analyzed
Platform usage
500+ heart attacks identified
AZORG one-year results with 32,800 ECGs analyzed
AZORG Health System (Heart Center Aalst)
AI-powered cardiac care coordination across six-hospital system to reduce treatment delays and improve heart attack detection across EMS, emergency departments, cardiology, and primary care
48-minute average reduction in time to treatment; 500+ heart attacks identified; 32,800+ ECGs analyzed; 350+ clinicians using monthly; median time to treatment of 64 minutes; 50%+ improvement in guideline compliance; up to 6 hours earlier treatment in complex cases
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Powerful Medical
Recent articles published on Powerful Medical's official website.
AZORG Hospitals Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform
Read on Powerful MedicalAZORG Hospitals Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform
Read on Powerful MedicalAI vs MD ECG-Reading for Cath Lab Activation (This Week in Cardiology, by Dr. John Mandrola)
Read on Powerful MedicalPowerful Medical Wins MedTech Innovator 2025
Read on Powerful MedicalPMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform
Read on Powerful Medical07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.